Frontiers in Cardiovascular Medicine

Original Research

Published on 21 Sep 2022

Global pattern of cardiovascular disease management in patients with cancer and impact of COVID-19 on drug selection: IRAQ—IC-OS survey-based study

in Cardio-Oncology

Hasan Ali Farhan
Israa Fadhil Yaseen
Mohammed Alomar
Daniel Lenihan
Susan Dent
Alexander R. Lyon

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.979631

2,683 views

Review

Published on 20 Sep 2022

Cardiotoxicity induced by immune checkpoint inhibitor: The complete insight into mechanisms, monitoring, diagnosis, and treatment

in Cardio-Oncology

Sridha Ganesh
Peng Zhong
Xiaoyang Zhou

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.997660

3,926 views
11 citations

Original Research

Published on 14 Sep 2022

The puzzling clinical presentation of fluoropyrimidines cardiotoxicity

in Cardio-Oncology

Linda Cucciniello
Ettore Bidoli
Elda Viel
Maria Laura Canale
Lorenzo Gerratana
Chiara Lestuzzi

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.960240

2,360 views
6 citations

Original Research

Published on 08 Sep 2022

Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways

in Cardio-Oncology

Vincenzo Quagliariello
Margherita Passariello
Annabella Di Mauro
Ciro Cipullo
Andrea Paccone
Antonio Barbieri
Giuseppe Palma
Antonio Luciano
Simona Buccolo
Irma Bisceglia

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.930797

5,861 views
40 citations

Original Research

Published on 25 Aug 2022

Racial and ethnic characteristics and cancer-specific survival in Primary Malignant Cardiac Tumors

in Cardio-Oncology

Mark M. Aloysius
Sanskriti Shrivastava
Chaitanya Rojulpote
Raza Naseer
Hamza Hanif
Milos Babic
Kenneth Gentilezza
Pranjal K. Boruah
Samir Pancholy

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.961160

2,158 views
5 citations

Review

Published on 23 Aug 2022

Non-coding RNAs in cancer therapy-induced cardiotoxicity: Mechanisms, biomarkers, and treatments

in Cardio-Oncology

Wanli Sun
Juping Xu
Li Wang
Yuchen Jiang
Jingrun Cui
Xin Su
Fan Yang
Li Tian
Zeyu Si
Yanwei Xing

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.946137

5,558 views
7 citations

Review

Published on 22 Aug 2022

Cardiogenic shock among cancer patients

in Cardio-Oncology

Anais Curtiaud
Clement Delmas
Justine Gantzer
Lara Zafrani
Martin Siegemund
Ferhat Meziani
Hamid Merdji

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.932400

7,122 views
5 citations

Case Report

Published on 17 Aug 2022

Case report: Recurrent syncope as initial symptom in a patient with neck lymphoma

in Cardio-Oncology

Yanfang Wu
Deyan Yang
Luxi Sun
Xiqi Xu
Peng Gao
Kangan Cheng
Taibo Chen
Zhongwei Cheng
Yongtai Liu
Quan Fang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.932798

3,906 views
2 citations

Original Research

Published on 16 Aug 2022

Left ventricular ejection fraction and cardiac biomarkers for dynamic prediction of cardiotoxicity in early breast cancer

in Cardio-Oncology

Florian Posch
Tobias Niedrist
Theresa Glantschnig
Saskia Firla
Florian Moik
Ewald Kolesnik
Markus Wallner
Nicolas Verheyen
Philipp J. Jost
Andreas Zirlik

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.933428

3,540 views
10 citations

Case Report

Published on 16 Aug 2022

Case report: A primary calcified cardiac mass in right atrium partially obstructs the tricuspid valve in a patient on hemodialysis

in Cardio-Oncology

Hongduan Liu
Xiaokang Tu
Hao Zhang
Chengming Fan
Haoyu Tan
Long Song
Qin Wu
Liming Liu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.950628

2,532 views
3 citations

Original Research

Published on 12 Aug 2022

Primary site as a novel prognostic factor for cardiovascular mortality post-radiotherapy in limited-stage small cell lung cancer: A large population-based study

in Cardio-Oncology

Yuwei Zhao
Fen Qin
Qingqi Ji
Wuyan Xia
Ben He

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.922811

2,329 views
4 citations

Case Report

Published on 11 Aug 2022

Genetics and clinical phenotype of Erdheim–Chester disease: A case report of constrictive pericarditis and a systematic review of the literature

in Cardio-Oncology

Lorenzo Bartoli
Francesco Angeli
Andrea Stefanizzi
Michele Fabrizio
Pasquale Paolisso
Luca Bergamaschi
Alessandro Broccoli
Pier Luigi Zinzani
Nazzareno Galiè
Paola Rucci

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.876294

4,624 views
10 citations

Original Research

Published on 09 Aug 2022

Variables associated with pulmonary hypertension screened by echocardiography in chronic myeloid leukemia patients on dasatinib therapy

in Cardio-Oncology

Wenying Jin
Sen Yang
Chao Yu
Tiangang Zhu
Qian Jiang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.960531

2,067 views
3 citations

Case Report

Published on 09 Aug 2022

Successful immune checkpoint inhibitor rechallenge after immune-related pericarditis: Clinical case series

in Cardio-Oncology

Adrian M. Chye
Ina I. C. Nordman
Aaron L. Sverdlov

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.964324

2,740 views
3 citations

General Commentary

Published on 09 Aug 2022

Commentary: Longitudinal changes in circulating metabolites and lipoproteins after breast cancer treatment

in Cardio-Oncology

Avirup Guha
Nickolas Stabellini
Alberto J. Montero

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.962698

1,775 views
2 citations

Review

Published on 03 Aug 2022

Anthracycline-induced cardiotoxicity: From pathobiology to identification of molecular targets for nuclear imaging

in Cardio-Oncology

Jeremy Jong
James R. Pinney
René R. Sevag Packard

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.919719

5,810 views
16 citations